Shanghai Pharmaceuticals Holding Co., Ltd
601607
Ранг среди акций
#2386
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
Цена акции
$2.43
Рыночная капитализация
$8.09B
Изменение (1 день)
-1.16%
Изменение (1 год)
-5.94%
Страна
CN
Торговля Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Категория
Healthcare
Коэффициент P/E для Shanghai Pharmaceuticals Holding Co., Ltd (601607)
Коэффициент P/E на October 2026 TTM: 12.56
Согласно последним финансовым отчетам и цене акций Shanghai Pharmaceuticals Holding Co., Ltd, текущий P/E (TTM) составляет 12.56. В конце 2024 у компании был P/E на уровне 17.09.
История P/E компании Shanghai Pharmaceuticals Holding Co., Ltd с 2001 по 2026
P/E на конец каждого года
| Год | P/E коэффициент | Изменить |
|---|---|---|
| 2026 (TTM) | 12.56 | 8.26% |
| 2025 | 11.60 | -32.13% |
| 2024 | 17.09 | 4.19% |
| 2023 | 16.40 | 48.37% |
| 2022 | 11.05 | -0.29% |
| 2021 | 11.09 | -8.65% |
| 2020 | 12.14 | -5.13% |
| 2019 | 12.79 | 7.07% |
| 2018 | 11.95 | -35.65% |
| 2017 | 18.57 | 12.84% |
| 2016 | 16.45 | -11.57% |
| 2015 | 18.61 | 8.74% |
| 2014 | 17.11 | -4.75% |
| 2013 | 17.97 | 23.58% |
| 2012 | 14.54 | 10.80% |
| 2011 | 13.12 | -58.75% |
| 2010 | 31.81 | -80.24% |
| 2009 | 160.94 | 221.88% |
| 2008 | 50.00 | -59.78% |
| 2007 | 124.31 | 208.48% |
| 2006 | 40.30 | 28.12% |
| 2005 | 31.45 | 47.65% |
| 2004 | 21.30 | 15.77% |
| 2003 | 18.40 | -31.84% |
| 2002 | 27.00 | 12.69% |
| 2001 | 23.96 | 0.00% |
P/E для схожих компаний или конкурентов
| Компания | P/E Ratio | Разница P/E | Страна |
|---|---|---|---|
| 26.02 | 107.20% |
US
|
|
| - | - |
US
|
|
| 34.08 | 171.35% |
US
|
|
| - | - |
US
|
|
| 45.62 | 263.25% |
AU
|
Как читать P/E Ratio?
Коэффициент цена/прибыль (P/E Ratio) отражает соотношение между ценой акции компании и её прибылью на акцию.
Низкий, но положительный P/E говорит о том, что компания приносит высокую прибыль при низкой оценке и может быть недооценена. Высокий отрицательный (близкий к 0) P/E указывает на значительные убытки.
Компании с P/E выше 30 или отрицательным считаются "акциями роста" — инвесторы ожидают роста или будущей прибыли.
Компании с положительным P/E ниже 10 считаются "ценностными акциями", т.е. уже прибыльны, но с низким потенциалом роста.